HIV.gov

Information on Coronavirus Disease 2019 (COVID-19)

CDC and HRSA's HIV/AIDS Bureau released FAQs about COVID-19 and HIV.

HHS HIV/AIDS Guidelines Panels released interim guidance for COVID-19 and Persons with HIV.

Additional information available at CDC.gov/coronavirus and USA.gov/coronavirus

HIV.gov's list of federal resources on COVID-19 and HIV.

Ready, Set, PrEP is a new nationwide program led by the U.S. Department of Health and Human Services (HHS). The Ready, Set, PrEP program provides pre-exposure prophylaxis (PrEP) medications at no cost to thousands of individuals who qualify. The program will expand access to PrEP medications, reduce new HIV infections, and bring us one step closer to ending the HIV epidemic in the United States. To check eligibility and enroll in the program click here.

The 2020 theme is "Resilience + Action: Ending the HIV Epidemic for Our Native Communities."

Learn about this observance and the work of the Indian Health Service; and the Ending the HIV Epidemic initiative.

Prevention and treatment are critical to reducing HIV’s impact in Native communities. PrEP is when people at risk for HIV take daily medicine to prevent HIV.

See if you qualify for free PrEP through the Ready, Set, PrEP program.

Subscribe to the Ending the HIV Epidemic: A Plan for America list to receive emails with program updates. Click here for information on the Ready, Set, PrEP programs, which provides PrEP medications at no cost to individuals who qualify, and to check eligibility and enroll in the program.

HHS released an RFP in support of the Ready, Set, PrEP program in December to identify a vendor(s) that can administer a customized solution that delivers PrEP medications to eligible recipients under the donation agreement with Gilead. Learn more here.

And, read about the Ending the HIV Epidemic: A Plan for America.